Continuous Glucose Monitoring Device Market Analysis and Forecast to 2031: By Component (Sensors, Transmitters & Receivers, and Integrated Insulin Pumps), Demographics (Child Population (≤14 years), Adult Population (>14 years)), End User (Clinics and Diagnostics Centers, ICUs, and Home Healthcare), and Region

A continuous glucose monitoring device is a small sensor that is placed under the skin to measure glucose levels in the interstitial fluid. The device is connected to a transmitter that sends data to a receiver. The receiver displays the glucose levels in real-time and can be worn on a belt or carried in a pocket. The device can be used to track glucose levels over time and to identify patterns.

Key Trends

The key trends in Continuous Glucose Monitoring Device technology are accuracy, miniaturization, and integration.

The accuracy of Continuous Glucose Monitoring Devices has been improving steadily over the years. The latest devices are able to provide readings that are within 5% of a patient’s actual blood sugar levels. This is a significant improvement from the early devices, which were often inaccurate by as much as 20%.

Miniaturization is another key trend in Continuous Glucose Monitoring Device technology. The latest devices are much smaller and more discreet than the early devices. This is important for patients who want to wear the devices all day and not have them be noticeable.

Integration is the third key trend in Continuous Glucose Monitoring Device technology. The latest devices are able to integrate with other devices and software, such as fitness trackers and blood sugar tracking apps. This allows patients to get a more complete picture of their blood sugar levels and their overall health.

Key Drivers

There are a few key drivers of the continuous glucose monitoring device market. Firstly, the number of people with diabetes is on the rise. According to the International Diabetes Federation, the number of people with diabetes is expected to reach 463 million by 2030. This increase in the number of people with diabetes is expected to drive the demand for continuous glucose monitoring devices.

Secondly, the prevalence of diabetes is increasing in developing countries. This is due to a number of factors, including the increasing prevalence of obesity and sedentary lifestyles. The increasing prevalence of diabetes in developing countries is expected to drive the demand for continuous glucose monitoring devices.

Thirdly, the increasing awareness of the benefits of continuous glucose monitoring is expected to drive the demand for these devices. Continuous glucose monitoring can help people with diabetes to better manage their condition and to avoid the serious complications associated with diabetes.

Finally, the advances in technology are expected to drive the demand for continuous glucose monitoring devices. Continuous glucose monitoring devices are becoming more accurate and easier to use. This is expected to increase the demand for these devices.

Restraints & Challenges

The main restraints on the Continuous Glucose Monitoring Device market are the high cost of the devices, the need for frequent calibration, and the lack of reimbursement in many countries.

The challenges facing the market are the need to miniaturize the devices, to improve their accuracy, and to develop new algorithms to interpret the data.

Market Segments

The Continuous Glucose Monitoring Device Market is segmented by component, demographics, end user, and region. Based on component, the market is segmented into transmitters & receivers and integrated insulin pumps; and sensors. On the basis of demographics, CGMS are categorized into child population (≤14 years) and adult population (>14 years). Based on end user, it is classified into clinics and diagnostics centers, ICUs, and home healthcare. Region-wise, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.

Key players

The Continuous Glucose Monitoring Device Market includes players such as Abbott Laboratories, Dexcom, Inc., A. Menarini Diagnostics, Echo Therapeutics, Inc., GlySens Incorporated, Johnson & Johnson, Medtronic plc, Senseonics Holdings, Inc., F. Hoffmann-La Roche Ltd., and LifeScan.

Why GIS?

Table of Contents

Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Continuous Glucose Monitoring Device Market Outlook
3.1. Continuous Glucose Monitoring Device Market segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Continuous Glucose Monitoring Device Market

Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Continuous Glucose Monitoring Device Market
4.3. Economic Impact Analysis

Chapter 5. Continuous Glucose Monitoring Device Market by Component
5.1. Market Overview
5.2. Sensors
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Transmitters & Receivers
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.4. Integrated Insulin Pumps
5.4.1. Market Size and Forecast, 2021-2031 ($Million)
5.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 6. Continuous Glucose Monitoring Device Market by Demographics
6.1. Market Overview
6.2. Child Population (≤14 years)
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Adult Population (>14 years)
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 7. Continuous Glucose Monitoring Device Market by End User
7.1. Market Overview
7.2. Diagnostics/Clinics
7.2.1. Market Size and Forecast, 2021-2031 ($Million)
7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.3. ICUs
7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.4. Home Healthcare
7.4.1. Market Size and Forecast, 2021-2031 ($Million)
7.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 8. Continuous Glucose Monitoring Device Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.2.3. North America Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.2.4. North America Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.2.5. North America Continuous Glucose Monitoring Device Market Size and Forecast by Country, 2021-2031, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.2.6.2. The U.S. Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.2.6.3. The U.S. Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.2.7. Canada
8.2.7.1. Canada Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.2.7.2. Canada Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.2.7.3. Canada Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.2.8. Mexico
8.2.8.1. Mexico Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.2.8.2. Mexico Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.2.8.3. Mexico Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.3.3. Europe Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.3.4. Europe Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.3.5. Europe Continuous Glucose Monitoring Device Market Size and Forecast by Country, 2021-2031, ($Million)
8.3.6. Germany
8.3.6.1. Germany Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.3.6.2. Germany Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.3.6.3. Germany Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.3.7. France
8.3.7.1. France Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.3.7.2. France Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.3.7.3. France Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.3.8. U.K.
8.3.8.1. U.K. Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.3.8.2. U.K. Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.3.8.3. U.K. Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.3.9. Spain
8.3.9.1. Spain Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.3.9.2. Spain Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.3.9.3. Spain Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.3.10. Italy
8.3.10.1. Italy Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.3.10.2. Italy Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.3.10.3. Italy Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.3.11.2. Rest of Europe Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.3.11.3. Rest of Europe Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific Continuous Glucose Monitoring Device Market Size and Forecast by Country, 2021-2031, ($Million)
8.4.3. Asia-Pacific Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.4.4. Asia-Pacific Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.4.5. Asia-Pacific Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.4.6. China
8.4.6.1. China Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.4.6.2. China Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.4.6.3. China Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.4.7. India
8.4.7.1. India Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.4.7.2. India Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.4.7.3. India Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.4.8. Japan
8.4.8.1. Japan Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.4.8.2. Japan Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.4.8.3. Japan Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.4.9. South Korea
8.4.9.1. South Korea Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.4.9.2. South Korea Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.4.9.3. South Korea Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.4.10. Rest of APAC
8.4.10.1. Rest of APAC Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.4.10.2. Rest of APAC Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.4.10.3. Rest of APAC Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.5. Rest of the World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of the World Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.5.3. Rest of the World Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.5.4. Rest of the World Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.5.5. Rest of the World Continuous Glucose Monitoring Device Market Size and Forecast by Country, 2021-2031, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.5.6.2. Latin America Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.5.6.3. Latin America Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.5.7.2. Middle East Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.5.7.3. Middle East Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)
8.5.8. Africa
8.5.8.1. Africa Continuous Glucose Monitoring Device Market Size and Forecast by Component, 2021-2031, ($Million)
8.5.8.2. Africa Continuous Glucose Monitoring Device Market Size and Forecast by Demographics, 2021-2031, ($Million)
8.5.8.3. Africa Continuous Glucose Monitoring Device Market Size and Forecast by End User, 2021-2031, ($Million)

Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Product Development
9.3.2. Product Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, and Collaborations
9.3.5. Mergers and Acquisitions

Chapter 10. Company Profiles
10.1. Abbott Laboratories
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. Dexcom, Inc.
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. A. Menarini Diagnostics
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Echo Therapeutics, Inc.
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. GlySens Incorporated
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Johnson & Johnson
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Medtronic plc
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. Senseonics Holdings, Inc.
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. F. Hoffmann-La Roche Ltd.
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. LifeScan
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis

*The list of company is subject to change during the final compilation of the report

 

 

 

 

 

 

Key players
  • Abbott Laboratories
  • Dexcom, Inc.
  • A. Menarini Diagnostics
  • Echo Therapeutics, Inc.
  • GlySens Incorporated
  • Johnson & Johnson
  • Medtronic plc
  • Senseonics Holdings, Inc.
  • F. Hoffmann-La Roche Ltd.
  • LifeScan
Market Segments

By Component

  • Sensors
  • Transmitters & Receivers
  • Integrated Insulin Pumps

By Demographics

  • Child Population (≤14 years)
  • Adult Population (>14 years)

By End User

  • Diagnostics/Clinics
  • ICUs
  • Home Healthcare

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Non-magnetic wheelchairs are wheelchairs that are not made…
Ultrasonic scalpels are a type of medical device…
Powered Surgical Instrument (PSI) is a medical device…
A surgical sealant is a material used to…
Medical Transport Boxes are highly specialized containers specifically…
Spay and neuter are two surgical procedures that…
The Life Science Analytics market size was USD…
Transplant Diagnostics is a field of diagnostics that…
Body contouring devices are devices that are used…
The global immunoassay market was valued at USD…